27 Mar 2007
United Therapeutics and Mochida Pharmaceutical Sign Remodulin Distribution Agreement for Japan
SILVER SPRING, Md., March 27 /PRNewswire-FirstCall/ -- United Therapeutics
Corporation (Nasdaq: UTHR) and Mochida Pharmaceutical Co., Ltd. announced
today that the companies have signed an agreement...
27 Mar 2007
Exclusive License Agreement for Modified Release Beraprost Assumed and Restated by Lung Rx, Inc.
SILVER SPRING, Md., March 27 /PRNewswire-FirstCall/ -- Lung Rx, Inc., a
wholly-owned subsidiary of United Therapeutics Corporation (Nasdaq: UTHR),
today announced that it has entered into an...
26 Feb 2007
United Therapeutics Announces Pulmonary Hypertension Opinion Leaders' Guidance On Intravenous Therapies
SILVER SPRING, Md., Feb. 26 /PRNewswire-FirstCall/ -- United Therapeutics
Corporation (Nasdaq: UTHR) today announced new guidance from pulmonary
arterial hypertension opinion leaders relating to...
SILVER SPRING, Md., Feb. 20 /PRNewswire-FirstCall/ -- United Therapeutics
Corporation (Nasdaq: UTHR) today announced financial results for the fourth
quarter and year ended December 31, 2006. "We...
SILVER SPRING, Md., Feb. 13 /PRNewswire-FirstCall/ -- United Therapeutics
Corporation (Nasdaq: UTHR) announced today that it will release its 2006
fourth quarter and annual financial results before...
12 Dec 2006
United Therapeutics Affiliate Initiates First-Ever Gene-Therapy Trial for Pulmonary Arterial Hypertension
SILVER SPRING, Md. and SATELLITE BEACH, Fla., Dec. 12
/PRNewswire-FirstCall/ -- Lung Rx, Inc., a wholly-owned subsidiary of United
Therapeutics Corporation (Nasdaq: UTHR), announced that its...
SILVER SPRING, Md., Nov. 13 /PRNewswire/ -- United Therapeutics Corporation
(Nasdaq: UTHR) announced today that its wholly owned subsidiary Unither Pharma,
Inc. has settled all patent litigation with...
SILVER SPRING, Md., Oct. 31 /PRNewswire-FirstCall/ -- United Therapeutics
Corporation (Nasdaq: UTHR) today announced financial results for the quarter
ended September 30, 2006. "We are pleased to...
SILVER SPRING, Md., Oct. 24 /PRNewswire-FirstCall/ -- United Therapeutics
Corporation (Nasdaq: UTHR) today announced the pricing of $210 million
principal amount of Convertible Senior Notes due 2011...